Areas of Expertise
  • Breast cancer
  • Lung cancer
  • Gynecological cancers
  • Urological cancers
  • Head and neck cancers
  • Lymphomas
  • Melanoma
  • Gastrointestinal system cancers

Education & Medical Training

  • 1996–2002 — Istanbul University Cerrahpaşa Faculty of Medicine — Medical Degree
  • 2002–2007 — Istanbul University Istanbul Faculty of Medicine — Internal Medicine Residency
  • 2008–2012 — Kocaeli University Faculty of Medicine — Medical Oncology Fellowship

Professional Experience

  • 2012–2014 — Kocaeli Derince Training and Research Hospital — Compulsory Service, Medical Oncology
  • 2014–2023 — Acıbadem Kocaeli Hospital — Medical Oncologist

Professional Memberships

  • Turkish Society of Medical Oncology
  • Kocaeli Medical Chamber

International Publications & Scientific Activities

Original Research Articles (SCI / SCI-Expanded / SSCI / AHCI)

  • Turgut F, Oflaz H, Namlı S, Alısır S, Tufan F, Temiz S, Umman S, Ecder T. Ambulatory blood pressure and endothelial dysfunction in autosomal dominant polycystic kidney disease. Ren Fail. 2007;29(8):979-984.
  • Bilici A, Uygun K, Seker M, Ustalioglu B, Aliustaoglu M, Temiz S, et al. Effect of tumor size on survival in pT3 gastric cancer: Multicenter experience. Oncologie. 2010;33:676-682.
  • Dogru A, Cabuk D, Sahin T, Dolasik I, Temiz S, Uygun K. Cardiotoxicity evaluation using speckle-tracking echocardiography in anthracycline-treated patients. Onkologie. 2013;36(12):712-716.
  • Bilici A, Dane F, Seker M, Ustaalioglu BB, Aliustaoglu M, Temiz S, et al. Is pT2 subdivision superior to lymph node metastasis for prognostic prediction in gastric cancer? Dig Dis Sci. 2011.
  • Uygun K, Bilici A, Kaya S, Ustalıoğlu BBO, Yıldız R, Temiz S, et al. XELIRI+Bevacizumab vs FOLFIRI+Bevacizumab in metastatic colorectal cancer. Asian Pac J Cancer Prev. 2013;14(4):2283-2288.
  • Aksu G, Dolasik I, Ensaroğlu F, Sener YS, Aydın HF, Temiz S, et al. Aprepitant efficacy in CINV prevention and QoL outcomes. Balkan Med J. 2013;30:64-67.
  • Erbağ G, Uygun K, Binnetoğlu E, et al. Aromatase inhibitor therapy and bone health: short-term outcomes. Contemp Oncol. 2015;19(5):374-377.
  • Kaya S, Gumus M, Gurbuz Y, Cabuk D, Acikgoz O, Temiz S, Uygun K. β-catenin and LEF-1 expression as prognostic markers in gastric cancer. Am J Transl Res. 2016;8(2):1228-1236.

  • Bilir C, Yıldız İ, Bilici A, et al. Hemoglobin change as predictor of TKI efficacy in metastatic RCC. Cancer Invest. 2017;35(4):248-255.

Case Reports, Technical Notes & Letters to the Editor

  • Kayacan SM, Vatansever S, Temiz S, et al. Alveolar echinococcosis involving liver, lung, and brain. Chin Med J. 2007.
  • Uysal M, Temiz S, Gül N, et al. Hypoglycemia due to ectopic insulin secretion from paraganglioma. Horm Res. 2007;67:292-295.
  • Temiz S. Efficacy of lapatinib + capecitabine in metastatic breast cancer with lung metastases. The Oncologist. 2010;15:108.
  • Aksu G, Ensaroğlu F, Dolasik I, et al. Complete response with intermittent sunitinib in metastatic RCC. J BUON. 2010;15(4):798-799.
  • Ensaroğlu F, Dolasik I, Halis H, et al. Small-cell carcinoma of the bladder: case review. Abant İzzet Baysal Med J. 2011;2:6.

International Conference Abstracts / Posters

  • Türkmen K, Oflaz H, Alışır S, et al. Coronary flow reserve impairment in ADPKD. JASN Abstracts; San Diego, 2006.
  • Turgut F, Oflaz H, Namlı S, et al. Ambulatory BP, microalbuminuria & endothelial dysfunction in ADPKD. JASN Abstracts; Philadelphia, 2005.
  • Yetimoğlu E, Çabuk D, Karaoz E, et al. CD44- / CD24- / LIN- cell percentage in breast tumors. Ann Oncol. 2012;23:9.

National Scientific Publications & Conference Contributions

  • Kayacan SM, Türkmen K, Vatansever S, Temiz S, et al. Diabetic foot infection causing gas gangrene. KLİMİK Congress; 2005.
  • Temiz S, Kayacan SM, Vatansever S, et al. Fatal purpura fulminans after upper respiratory infection. KLİMİK; 2005.
  • Vatansever S, Türkmen K, Kayacan SM, Temiz S, et al. Gas gangrene in diabetic foot infection. 7th National Internal Medicine Congress; 2005.
  • Temiz S, Uysal M, Kayacan SM, et al. Two clinical presentations of acute leukemia. 7th National Internal Medicine Congress; 2005.
  • Mert M, Temiz S, Üzüm A.K., et al. Dexamethasone suppression test & MS patients. TEMD Congress; 2005.
  • Uysal M, Temiz S, et al. Paraganglioma-related hypoglycemia. TEMD Congress; 2005.
  • Mert M, Temiz S, Üzüm A.K., et al. Widespread metastasis under infliximab. TEMD; 2005.

National Studies / Clinical Trials

  • Phase III trial of BIBF 1120 + pemetrexed vs placebo + pemetrexed in advanced NSCLC
  • Phase III double-blind study of ipilimumab in chemotherapy-naïve CRPC
  • Breast-Türk Early-Stage Breast Cancer Registry (2009-2014)

Resume

Education & Medical Training

  • 1996–2002 — Istanbul University Cerrahpaşa Faculty of Medicine — Medical Degree
  • 2002–2007 — Istanbul University Istanbul Faculty of Medicine — Internal Medicine Residency
  • 2008–2012 — Kocaeli University Faculty of Medicine — Medical Oncology Fellowship

Professional Experience

  • 2012–2014 — Kocaeli Derince Training and Research Hospital — Compulsory Service, Medical Oncology
  • 2014–2023 — Acıbadem Kocaeli Hospital — Medical Oncologist

Professional Memberships

  • Turkish Society of Medical Oncology
  • Kocaeli Medical Chamber

Publications

International Publications & Scientific Activities

Original Research Articles (SCI / SCI-Expanded / SSCI / AHCI)

  • Turgut F, Oflaz H, Namlı S, Alısır S, Tufan F, Temiz S, Umman S, Ecder T. Ambulatory blood pressure and endothelial dysfunction in autosomal dominant polycystic kidney disease. Ren Fail. 2007;29(8):979-984.
  • Bilici A, Uygun K, Seker M, Ustalioglu B, Aliustaoglu M, Temiz S, et al. Effect of tumor size on survival in pT3 gastric cancer: Multicenter experience. Oncologie. 2010;33:676-682.
  • Dogru A, Cabuk D, Sahin T, Dolasik I, Temiz S, Uygun K. Cardiotoxicity evaluation using speckle-tracking echocardiography in anthracycline-treated patients. Onkologie. 2013;36(12):712-716.
  • Bilici A, Dane F, Seker M, Ustaalioglu BB, Aliustaoglu M, Temiz S, et al. Is pT2 subdivision superior to lymph node metastasis for prognostic prediction in gastric cancer? Dig Dis Sci. 2011.
  • Uygun K, Bilici A, Kaya S, Ustalıoğlu BBO, Yıldız R, Temiz S, et al. XELIRI+Bevacizumab vs FOLFIRI+Bevacizumab in metastatic colorectal cancer. Asian Pac J Cancer Prev. 2013;14(4):2283-2288.
  • Aksu G, Dolasik I, Ensaroğlu F, Sener YS, Aydın HF, Temiz S, et al. Aprepitant efficacy in CINV prevention and QoL outcomes. Balkan Med J. 2013;30:64-67.
  • Erbağ G, Uygun K, Binnetoğlu E, et al. Aromatase inhibitor therapy and bone health: short-term outcomes. Contemp Oncol. 2015;19(5):374-377.
  • Kaya S, Gumus M, Gurbuz Y, Cabuk D, Acikgoz O, Temiz S, Uygun K. β-catenin and LEF-1 expression as prognostic markers in gastric cancer. Am J Transl Res. 2016;8(2):1228-1236.

  • Bilir C, Yıldız İ, Bilici A, et al. Hemoglobin change as predictor of TKI efficacy in metastatic RCC. Cancer Invest. 2017;35(4):248-255.

Case Reports, Technical Notes & Letters to the Editor

  • Kayacan SM, Vatansever S, Temiz S, et al. Alveolar echinococcosis involving liver, lung, and brain. Chin Med J. 2007.
  • Uysal M, Temiz S, Gül N, et al. Hypoglycemia due to ectopic insulin secretion from paraganglioma. Horm Res. 2007;67:292-295.
  • Temiz S. Efficacy of lapatinib + capecitabine in metastatic breast cancer with lung metastases. The Oncologist. 2010;15:108.
  • Aksu G, Ensaroğlu F, Dolasik I, et al. Complete response with intermittent sunitinib in metastatic RCC. J BUON. 2010;15(4):798-799.
  • Ensaroğlu F, Dolasik I, Halis H, et al. Small-cell carcinoma of the bladder: case review. Abant İzzet Baysal Med J. 2011;2:6.

International Conference Abstracts / Posters

  • Türkmen K, Oflaz H, Alışır S, et al. Coronary flow reserve impairment in ADPKD. JASN Abstracts; San Diego, 2006.
  • Turgut F, Oflaz H, Namlı S, et al. Ambulatory BP, microalbuminuria & endothelial dysfunction in ADPKD. JASN Abstracts; Philadelphia, 2005.
  • Yetimoğlu E, Çabuk D, Karaoz E, et al. CD44- / CD24- / LIN- cell percentage in breast tumors. Ann Oncol. 2012;23:9.

National Scientific Publications & Conference Contributions

  • Kayacan SM, Türkmen K, Vatansever S, Temiz S, et al. Diabetic foot infection causing gas gangrene. KLİMİK Congress; 2005.
  • Temiz S, Kayacan SM, Vatansever S, et al. Fatal purpura fulminans after upper respiratory infection. KLİMİK; 2005.
  • Vatansever S, Türkmen K, Kayacan SM, Temiz S, et al. Gas gangrene in diabetic foot infection. 7th National Internal Medicine Congress; 2005.
  • Temiz S, Uysal M, Kayacan SM, et al. Two clinical presentations of acute leukemia. 7th National Internal Medicine Congress; 2005.
  • Mert M, Temiz S, Üzüm A.K., et al. Dexamethasone suppression test & MS patients. TEMD Congress; 2005.
  • Uysal M, Temiz S, et al. Paraganglioma-related hypoglycemia. TEMD Congress; 2005.
  • Mert M, Temiz S, Üzüm A.K., et al. Widespread metastasis under infliximab. TEMD; 2005.

National Studies / Clinical Trials

  • Phase III trial of BIBF 1120 + pemetrexed vs placebo + pemetrexed in advanced NSCLC
  • Phase III double-blind study of ipilimumab in chemotherapy-naïve CRPC
  • Breast-Türk Early-Stage Breast Cancer Registry (2009-2014)

Quick Appointment
Randevu alabilmek için hastane ve branş seçmeniz gerekmektedir.
Create an Appointment
Calendar

Thank You

We will contact you as soon as possible. We wish you healthy days!